Relapsed / Refractory MDS
1 clinical trials · Condition
◉ Watch Relapsed / Refractory MDS
| Record | Firm | Date |
|---|---|---|
| Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms. (NCT06359002) | Byondis B.V. | 2024-06-25 |
Track Relapsed / Refractory MDS automatically
Every clearance here is in the API, with alerts when new ones post.